When was Roche founded?

Roche was founded in 1896 and raised its 1st funding round 108 years after it was founded.

Where is Roche located?

Roche is headquartered in Basel, Switzerland. It is registered at Little Falls, New Jersey.

How many employees does Roche have?

As of Aug 31, 2026, the latest employee count at Roche is 107716.

Is Roche a funded company?

Roche is a funded company, having raised an undisclosed amount across 18 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 01, 2004.

When was the latest funding round of Roche?

Roche's latest funding was a $***** Post IPO round on May 21, 2023, with participation from 1 investor.

What is the annual revenue of Roche?

Annual revenue of Roche is between £10M and £50M as on Jul 31, 2022

Where does Roche rank among its competitors?

Roche ranks 9th amongst 2416 active competitors, of which 156 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Roche?

Roche's top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Roche - 2026 Company Profile, Team, Funding, Competitors & Financials

Roche is a public company based in Basel (Switzerland), founded in 1896 by Fritz Hoffmann La Roche. It operates as a Developer of pharmaceuticals and diagnostics kits. Roche has raised an undisclosed amount in funding. The company has 2416 active competitors, including 156 funded and 251 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.

Company Details

Developer of pharmaceuticals and diagnostics kits for multiple diseases. It manufactures diagnostic equipment and reagents for research and medical diagnostic applications. In 2022, the company recorded annual revenues of $66.26B and a net profit of $13.01B

Website: www.roche.com/
Social
Email ID: *****@roche.com
Phone Number: +41 **********
Registered Address: Little Falls, New Jersey

Key Metrics

Founded Year

1896

Location

Basel, Switzerland

Stage

Public

Latest Funding Round

Post IPO, May 21, 2023, $*****

Investors

Gilde Healthcare & 12 more

Ranked

9^th among 2416 active competitors

Annual Revenue

£10M - £50M as on Jul 31, 2022

Employee Count

107,716 as on Aug 31, 2026

Investment & Acquisitions

Mironid & 92 more

Similar Companies

AbbVie & 2313 more

Exit Details

Public

View Roche's full profile

Roche is associated with 29 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GS pharma s. r. o. CIN: 27502953 , Czech Republic, Active	Oct 10, 2006	-	-
K.H.A. Invest s.r.o. CIN: 27419479 , Czech Republic, Active	Jan 26, 2006	-	-
Roxx International s.r.o. CIN: 27192474 , Czech Republic, Active	Nov 02, 2004	-	-
AL-LA Praha,s.r.o. CIN: 25659642 , Czech Republic, Active	Apr 14, 1998	-	-
TEHREN INVEST s.r.o. CIN: 19945167 , Czech Republic, Active	Nov 21, 2023	-	-
Swiss Pharma PLUS s.r.o. CIN: 19721692 , Czech Republic, Active	Sep 13, 2023	-	-
La Group Market s.r.o. CIN: 19536925 , Czech Republic, Active	Aug 01, 2023	-	-
EURO TRADING PRAGUE SYGMA s.r.o. CIN: 19268106 , Czech Republic, Active	Apr 20, 2023	-	-
F.group partner, s.r.o. CIN: 19284357 , Czech Republic, Active	Apr 26, 2023	-	-
Diabetes Import s.r.o. CIN: 09831576 , Czech Republic, Active	Jan 16, 2021	-	-
Roche Real Invest, s.r.o. CIN: 07857691 , Czech Republic, Active	Feb 01, 2019	-	-
WORLD TRADING COMPANY s. r. o. CIN: 07789831 , Czech Republic, Active	Jan 10, 2019	-	-
International PTR s.r.o. CIN: 07756046 , Czech Republic, Active	Jan 02, 2019	-	-
SANDORTE trade s.r.o. CIN: 07439903 , Czech Republic, Active	Sep 06, 2018	-	-
International Trade Company s.r.o. CIN: 06303412 , Czech Republic, Active	Jul 27, 2017	-	-
Biopharma-design s.r.o. CIN: 06139825 , Czech Republic, Active	May 31, 2017	-	-
Roche Privacy GmbH CIN: B8536_HRB718233 , Germany, Active	Jun 08, 2018	-	-
ROFU (THAILAND) COMPANY LIMITED CIN: 0105558123931 , Thailand, Active	Jul 29, 2015	$50M - $100M (As on Dec 31, 2022)	-
ROCHE DIAGNOSTICS (THAILAND) LTD. CIN: 0105535102139 , Thailand, Active	Jul 13, 1992	$100M - $500M (As on Dec 31, 2023)	-
ROCHE DIAGNOSTICS GMBH CIN: 929234677 , Norway, Active	Jul 22, 1920	-	-
ROCHE SERVICES AND SOLUTIONS (INDIA) PRIVATE LIMITED CIN: U63119TS2023FTC177783 , India, Active	Oct 09, 2023	₹50 - ₹100 Cr (As on Mar 31, 2025)	-
ROCHE HEALTHCARE LIMITED CIN: 2992723 , United Kingdom, Active	Nov 20, 1994	£10M - £50M (As on Jul 31, 2022)	365 (As on Jul 31, 2022)
ROCHE ENGINEERING LTD CIN: 12649092 , United Kingdom, Active	Jun 04, 2020	£0 - £1M (As on Jun 30, 2024)	1 (As on Jun 30, 2024)
F. Hoffmann-La Roche Ltd CIN: 105.815.381 , Switzerland, Active	Sep 30, 1896	-	-	-
ROCHE PRODUCTS (INDIA) PRIVATE LIMITED CIN: U74999MH1994PTC077533 , India, Active	Apr 05, 1994	₹1,000+ Cr (As on Mar 31, 2025)	284 (As on Mar 01, 2026)
ROCHE INDIA HEALTHCARE INSTITUTE CIN: U85320MH2019NPL330482 , India, Active	Sep 12, 2019	0 - ₹10 Cr (As on Mar 31, 2025)	-
ROCHE -BOBOIS USA LIMITED CIN: 132788222 , United States, Active	Dec 31, 1999	-	227 (As on Dec 31, 2024)	-
Hoffmann-la Roche Inc. CIN: 220994270 , United States, Active	Dec 26, 999	-	1760 (As on Dec 31, 2024)	-
ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED CIN: U85195MH1988PTC141417 , India, Active	Jun 07, 1988	₹1,000+ Cr (As on Mar 31, 2025)	442 (As on May 01, 2026)

Roche got listed on Dec 05, 2002.

Click here to take a look at Roche's IPO in detail

Roche has raised funding over 18 rounds. Its first funding round was on May 01, 2004. Its latest funding round was a Post IPO round on May 21, 2023 for $*****. 1 investor participated in its latest round. Roche has 13 institutional investors.

Here is the list of recent funding rounds of Roche:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 21, 2023	8300341	Post IPO	5647591	8026142	3115057	4560663
Jun 01, 2022	6852421	Grant (prize money)	6481599	9992263	3014344	Europa
Aug 05, 2021	7085146	Post IPO	4051915	6532653	4016033	SoftBank Group

Access funding benchmarks and valuations. Sign up today!

View details of Roche's funding rounds and investors

The founders of Roche is Fritz Hoffmann La Roche.

Here are the details of Roche's key team members:

Fritz Hoffmann La Roche: Former Founder of Roche and founder of 1 other company.

Roche's Board of Directors

Roche's board has 4 active members. Alan Hippe, Claudia Böckstiegel and Thomas Schinecker are part of team and Urs Lauffer is independent board member.

Here is the list of Roche's board of directors:

Name	Type	Representing	Status	Duration
idklkwc	Team	-	Current	6y 2m
bbuwuga	Team	-	Current	2y 5m
{chcmpj	Team	-	Current	5y 7m
Urs Lauffer	Independent board member	-	Current	-

View details of Roche's Founder profiles and Board Members

Roche's employee count trend

Roche has 107,716 employees as of Aug 26. Here is Roche's employee count trend over the years:

Uncover Roche's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Roche include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Roche, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	71/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Roche's competitors? Click here to see the top ones

Roche has made 44 investments in companies including Mironid and Mission Therapeutics. Roche has also acquired 49 companies including 89bio and Poseida Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Aug 05, 2026	Investments	Mironid	2015	Glasgow (United Kingdom)
Oct 15, 2025	Investments	Mission Therapeutics	2011	Cambridge (United Kingdom)
Sep 17, 2025	Acquisition	89bio	2018	San Francisco (United States)